At #ESMO26 we had the pleasure of interviewing Matthew Lee (@cityofhope) who discussed the development of BG-C477, a CEA-targeting ADC, and early results in non-small cell lung cancer. He also explores how CEA compares with established NSCLC ADC targets, and whether its expression and internalisation support efficient payload delivery 🎯🫁

Coming soon to http://VJOncology.com 👀

#LungCancer #NSCLC #ADC @myESMO